# Commission Implementing Decision of 25 April 2013 allowing Member States to extend provisional authorisations granted for the new active substances acequinocyl, aminopyralid, ascorbic acid, flubendiamide, gamma-cyhalothrin, ipconazole, metaflumizone, orthosulfamuron, Pseudomonas sp. strain DSMZ 13134, pyridalil, pyroxsulam, spiromesifen, thiencarbazone and topramezone (notified under document C(2013) 2246) (Text with EEA relevance) (2013/205/EU), Signature

Extent: E+W+S+N.I.

Done at Brussels, 25 April 2013.
For the Commission
Tonio Borg
Member of the Commission

---
Source: https://www.legislation.gov.uk/eudn/2013/205/signature (the official version)
Page: https://openlegislation.uk/eu-decision-2013-205/signature
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.